Pandion Therapeutics sought $58 million Series A funding to advance drug programs for autoimmune and inflammatory diseases Read more
OBI Pharma confirms FDA’s clearance of IND for Phase 1 Study of Monoclonal Antibody Cancer Immunotherapy Read more
APRINOIA Therapeutics finances US$11.1 Million Series B for developing imaging diagnostic and therapeutic pipelines Read more
Nils Hauptmann appointed Aerie Pharma’s Director of Regulatory Affairs and Pharmacovigilance Read more
FDA issues 510(k) clearance to Centric Medical for Cannulated Screw Internal Fixation System Read more